This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Prognostic analysis of neutralizing antibody levels in patients with COVID-19 (preprint)
researchsquare; 2021.
Preprint
in English
| PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-337123.v1
ABSTRACT
Background:
In the high incidence period of COVID-19, it is very important to quickly classify and evaluate the prognosis of patients through limited clinical antibody data. Methods Chemiluminescence immunoassay was used to detect serum IgM and IgG concentrations in 1951 patients diagnosed with COVID-19, and R language was used to analyze the influence of factors such as antibody, age, gender and concomitant diseases on the prognosis of SARS-CoV-2 patients. Results The results showed that the incidence of COVID-19 was consistent with the characteristics of the elderly, and patients with hypertension, diabetes, stroke, hypoalbuminemia and anemia were at increased risk of critical illness ( p
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-RESEARCHSQUARE
Main subject:
COVID-19
Language:
English
Year:
2021
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS